Abstract
Purpose
The recognition of adverse drug reactions (ADRs) is an important part of daily clinical work. However, medical education in this field is mostly drug-based and does not address adequately the complexity of this field regarding individual risk factors and polypharmacy. This study investigates the potential of the web-based serious game SeeMe (side-effect exposure—medical education) in pharmacological education of medical students to improve the recognition of relevant ADRs.
Methods
One hundred fifty-seven medical students were recruited to evaluate the serious game SeeMe. SeeMe was developed to improve knowledge and recognition of ADRs in clinical practice. Players take on the role of a physician trying to understand fictional patients with ADRs. Before and after an 8-week playing period, an evaluation was carried out through a pre- and post-questionnaire and a pre- and post- knowledge test.
Results
The students achieved significantly better results in the knowledge test, as almost twice as many exam-relevant questions were answered correctly (p < 0.001). The serious game had a positive effect on the students’ perception of the importance of ADRs.
Conclusion
This study demonstrates the potential of web- and case-based fictional serious games in medical education. The improved recognition of side effects represents a crucial step for education and training in clinical pharmacology. Future versions of the serious game may take this further and focus on training in the treatment of ADRs and their relevance in various healthcare professions.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Recognizing adverse drug reactions (ADR) in everyday clinical practice is a challenge for medical disciplines because ADRs can present themselves differently in each individual patient [1]. Next to patient-specific risk factors like age or comorbidities, polypharmacy and pharmacogenetic (PGx) aspects play a role [2,3,4]. ADRs are clinically highly relevant and approximately 6.5% of all admissions to the emergency department can be related to an ADR [5,6,7]. However, due to its various manifestations, ADRs often remain undetected [5]. This is a critical challenge for our healthcare system, as pharmacovigilance research relies on the detection and reporting of ADRs to improve patient safety in drug therapy [8].
Teaching pharmacological knowledge and skills in relation to ADRs is a challenge in studies of medicine and is usually based on books or tables listing the known side effects associated with the use of certain drugs. A literature review concluded that there is an urgent need to improve education in pharmacovigilance [9]. And 5 years ago, a stakeholder meeting organized by the Netherlands Pharmacovigilance Centre Lareb on behalf of the World Health Organization (WHO) even introduced a core curriculum for teaching drug safety aspects at universities [10].
In the context of increasing digitalization, more and more opportunities have arisen in recent years to establish digital learning formats within traditional medical education. Particularly, the SARS-CoV2 pandemic has shown how urgently new learning formats are needed to maintain practical training in the medical field [11, 12]. Serious games are defined as digital games designed for purposes beyond mere entertainment, aiming to educate, train, and solve problems in various fields, including medical education. A serious game-based approach can provide a safe and secure introduction to patient contact and reinforce theoretical content. It may be at least as effective as traditional training and even superior in terms of improving knowledge, skills, and satisfaction [13]. For example, a serious game for primary healthcare education showed to be just as effective as studying through books [14]. A recent review concludes that serious games are, and game-based learning is becoming more popular in medical education due to its innovative, interactive methods that enhance student learning experiences and improve outcomes [15]. Such learning formats offer the opportunity to deliver learning content in a more individual and hands-on way, regardless of the time spent. There is an increased demand for learning formats such as serious games in education, particularly among pharmacy students [16,17,18]. However, to the best of our knowledge, there is currently no serious game available that allows the training of ADR recognition.
The current study investigated whether a newly developed serious game called SeeMe (side-effect exposure—medical education) can be used to train medical students’ recognition of ADRs in clinical pharmacology.
Methods
Serious game development
The development of the serious game SeeMe was part of the European U-PGx project (European Union’s Horizon 2020 research and innovation program, grant agreement no. 668353) and the Exploratory Teaching Space program of the RWTH Aachen University (Germany). Within the framework of a European-wide cooperation, the U-PGx project tested the use of PGx guided treatment for the reduction of ADRs [4]. The development of the game was part of the education and training program developed for successful implementation of PGx-guided treatment into clinical practice. The game is accessible at https://upgx.eu/category/documents/.
The game was designed and developed in-house by the Audiovisual Media Center of the Medical Faculty, RWTH Aachen University, in close cooperation with the Institute of Clinical Pharmacology and is available to medical students from their third year onwards at RWTH Aachen University.
SeeMe is a web- and case-based serious game in which the player takes on the role of a physician and faces 47 patient cases. Fictional patients can present with a wide variety of complaints that can be related to a relevant ADR of a previous drug therapy. The emphasis is put on the recognition of ADRs in a patient with different drugs and comorbidities rather than the enumeration of side effects linked to drugs such as presented in pharmacological courses or books. All cases reflect clinically relevant and common ADRs, based on questions frequently asked in the final state exams in Germany and are graphically illustrated. For an extensive overview of all 47 cases see Supplementary Table S1. A short impression of the game interface and one of a fictional patient is given in Fig. 1a, b. The player must arrive at a diagnosis, think about potential drug treatments for that diagnosis and identify the ADR by independently asking about complaints (Fig. 1e) and by assessing medical findings such as a physical examination, laboratory values, imaging, or PGx data (Fig. 1c). During the game, players can request help and tips from a virtual expert (Fig. 1d). At the end of each patient case, the player must answer whether the symptoms of the current patient are mainly due to ADRs, and which diagnoses should be made. In addition, two 5-point Likert scales assess whether the players rate the current patient case as easy and realistic. After confirming the answers, players receive feedback, and, if they wish to complete the case (in which case they cannot replay the current case), they can access the solution with an explanation of the case and the corresponding ADR.
Study population
The evaluation of SeeMe was conducted monocentric at the Medical Faculty of the RWTH Aachen University, Germany. For this purpose, medical students were recruited who were already in clinical and practical training within their studies and had patient contact starting from the third year onwards. Students participated voluntarily as part of a course, and informed consent was obtained from all participants. The study period was from 07/2021 to 02/2024 and comprised three study years. The study was conducted in digital form and participation was anonymous, with an anonymized identifier used to link online questionnaires and game data. The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the local ethical committee (EK 230/21) of the medical faculty of RWTH Aachen University.
Game evaluation, knowledge tests, and study course
Before the study, a short lecture was given on the relevance of ADRs, and the serious game was introduced. An anonymous online survey was conducted asking students’ attitudes and self-assessment towards pharmacology, study progress, and the importance of ADRs. The survey was presented through the online platform LimeSurvey [19]. Items needed to be rated on a 5-point Likert scale ranging from 1 “don’t agree at all” to 5 “totally agree.” In addition, the students were tested on their knowledge of ADRs using an online formative test. The knowledge test was adapted to the examination mode of German state examinations, using 30 multiple choice questions (Supplementary Table S2). The questions were designed in pairs to cover comparable topics of drug-ADR combinations in pre- and post-serious game knowledge tests. The questions were prepared by two physicians under a dual control principle and supervised by a professor of clinical pharmacology. This was done to ensure comparable levels of severity in both exams, before and after game play. Due to the formative nature of the knowledge test, there was an option to answer with “I don’t know.” Students were informed that this test had no impact on course grades.
Following the pre-evaluation, students had 8 weeks to play the serious game. They were required to play all cases and were allowed to repeat cases as many times as they liked. Subsequently, participants were surveyed again with an online questionnaire. The post-questionnaire assessed game experience and usability, as well as the subjective learning progress. Usability was assessed using the System Usability Scale (SUS) [20, 21]. The SUS is a ten-item scale that provides a single number, ranging from 0 to 100, representing a composite measure of overall usability. In addition, students’ knowledge was assessed a second time. The second knowledge test contained the same subject as before and was not changed in severity but was adjusted in language and logical linkage.
Statistical analysis
Statistical analyses were performed in R [22]. For all analyses, the level of significance was set at α = 0.05. Epidemiological data of the participants were collected and reported in absolute values and percentages and were appropriate with mean (M) and standard deviation (SD). To test whether students’ opinions changed and whether they were able to increase their knowledge, pre- and post- questionnaires, and knowledge tests were compared. Because of a skewed distribution and lack of homogeneity of variance for several items, Mann–Whitney U tests were applied for pre- and post-comparison using the R package stats. The rcompanion package was used to calculate the effect size r. To test the potential effect of study year and gender on knowledge and the potential interaction between study year, gender, and knowledge gain in the pre- and post- exam, a linear mixed-effects model with time (pre, post) as within-subject factor and study year (3rd to 5th) and gender (female, male, divers) as between-subject factors was conducted using the nlme package. Further, the MuMIn package was used to provide the marginal and conditional R. The ggplot2 and ggstatsplot packages were utilized for data visualization.
Results
Study cohort
In total, N = 157 students enrolled and completed the serious game course. Of them, 77.7% (n = 122) were female and 22.3% (n = 35) were male. Characteristics of the cohort are summarized in Table 1.
Around a third of students (30%, n = 46) indicated that they use books as their primary learning medium, and 21% (n = 33), respective 17% (n = 26) that they already used apps or videos as a learning medium. Although only some participants (n = 31) play online games in their leisure time, participants stated pre-game experience that they were open to online learning games to deepen and consolidate their knowledge (mean 4.8, SD 0.6).
Evaluation: pre- and post-gaming
There was high agreement of a mean 4.2 (SD 0.8) on a 5-point Likert scale, that ADRs were realistic and transferable to clinic. The usability of the serious game was rated as good, with a SUS mean of 77.7 (SD 15.3). See Table 2 for an overview of the self-assessments pre- and post-serious game play.
All items ranked anonymously on a 5-point Likert scale from 1 “don’t agree at all” to 5 “agree totally.” Item 3 was only assessed once after using the serious game. SD standard deviation.
Confidence to handle medications and to prescribe them was low across time (pre-, post-game play) but still improved significantly after using SeeMe from mean 1.8 (SD 0.8) to 2.4 (SD 0.9), V = 790.5, p < 0.001, r = − 0.36. Along with this, a certain anxiety to harm patients with prescribing a medication reduced slightly, yet significantly from 3.8 (SD 0.9) to 3.5 (SD 0.9), V = 3078, p = 0.001, r = 0.14. The wish for more support and training in the field of pharmacology was underlined by participants with an overall agreement of a mean of 4.4 (SD 0.7) before and 4.3 (SD 0.7) after playing the game (V = 1231.5, p = 0.02, r = 0.12). Students stated that their knowledge improved modestly after using the serious game with a mean 3.8 (SD 0.9), although it was still considered to be low. Yet, students highly agreed that the use of the serious game made the topic more accessible to them (mean 4.2, SD 1.0).
Exam results
Due to a technical error, the exam results were only saved for the years 2021 to 2022 (n = 110). Test results in the formative exam during these years improved significantly from 31% (9.4, SD 4.9) correct answers before playing the game to 55% (16.6, SD 5.1) correct answers after game play (Fig. 2), i.e., a significant main effect of time (pre, post) was found, F(1,98) = 324.97, p < 0.001. Notably, the marginal R2 for the fixed effects was 0.56, and the conditional R2 for both fixed and random effects was 0.75. Further, there was a significant effect of study year, and students in higher semesters reached better exam results, F(5,98) = 14.63, p < 0.001. However, the interaction between study year and time (pre-, post-game play) was not significant, indicating that the year of study did not influence the increase in knowledge, F(5,98) = 1.25, p = 0.29. Similarly, no significant gender differences were observed in exam results, F(1,98) = 0.55, p = 0.46.
Game data
More than half of the students, 56.1% (n = 88) played the game at least twice a week. Students started 16,939 times a patient case, of which 98.1% (n = 16,615) patient cases were finished. Each student finished between 30 and 47 cases. On average, in 63.6% (n = 7408) of game sessions, students agreed that patient cases were realistic, and in only 31.2% (n = 3652) of game sessions, students agreed that patient cases were easy. Students used the options to ask questions to the patient between 0 and 27 times and requested help from the fictional doctor within the game between 0 to 42 times. In 70% (n = 11,865 out of 16,939) of game sessions, students identified the presence or absence of ADRs correctly.
Discussion
In this study, we reversed the conventional learning method and concentrated on recognizing ADRs in patients, as well as identifying the probable drugs that may have typically caused these ADRs, within the context of a serious pharmacology game SeeMe. The current evaluation of SeeMe showed a marked improvement in the recognition of ADRs in medical students. Students were able to significantly improve their exam-relevant knowledge by answering almost twice as many questions correctly. Generally, the serious game was rated positively by most students, particularly regarding the learning effect, and was classified as realistic and transferable to clinical practice. While several studies have already shown that serious games are equivalent to traditional learning formats and can improve knowledge [13, 23], to our knowledge, this is the first published study on a serious game to improve ADR recognition in medical students. Notably, although the serious game increased students’ confidence in prescribing medication and reduced their fear of harming patients, confidence remained low. This is reasonable, as students still need a lot of training to enable working as physicians, as here students starting from the 3rd year of training were enrolled. In addition, treatment was only indirectly trained through the correct recognition of ADRs. This emphasises the need for increased and sufficient training of medical students in relation to ADRs.
Personalized medicine using PGx promised to improve drug efficacy and drug safety [24, 25]. The European Ubiquitous Pharmacogenomics (U-PGx) project showed that the use of a 12-gene PGx panel along with treatment recommendations can reduce the occurrence of ADRs by 30% [4]. However, relevant barriers and challenges to the implementation of PGx in clinical work include a targeted education and its useful implementation [26, 27]. A symptom-based approach such as the current serious game is considered a good tool to better integrate existing knowledge about PGx and the resulting clinically relevant ADRs. Training in the recognition of ADRs in everyday clinical practice is particularly important to avoid harming patients [28]. Education and training, including the development of the here presented serious game, were therefore part of the U-PGx project. Often a drug-based approach needs to be taken to identify potential ADRs, whereas in clinical reality, the focus is primarily on a symptom that needs to be associated with a drug. However, the manifestation of an ADR depends on numerous individual factors and can present variably in clinical practice [1]. As an example, there are many drugs causing agranulocytosis a potentially life-threatening ADR [29]. Thus, besides knowing facts and reproducing them in a medical term in an exam, recognition in clinical work is most crucial and should be trained to improve drug safety.
The results presented should be interpreted considering some limitations and recommendations for future follow-up studies should be considered. First, knowledge tests were carried out directly after playing the game. This does not allow any conclusions to be drawn about long-term learning effects. Future studies should carry out knowledge tests later and possibly evaluate the application of the acquired knowledge in practice. In addition, the effect of certain knowledge questions or topics might be addressed in a follow-up study. Due to a technical error, only the overall knowledge test results could be retrieved in the current study. Further, students also attended other lessons and training sessions in addition to the serious game. It therefore cannot be completely ruled out that at least part of the learning success can be attributed to learning outside the serious game. In this context, however, it should be noted that the results of the study were comparable across and independent of the study years, and since the knowledge tests were formative, no learning was provoked by the study design.
Future studies might investigate the game play in more detail. In the current study, players were allowed to take as much time as desired to finish a patient case. As it was also possible to take longer breaks during a patient’s game, the actual playing time cannot be tracked and compared between patient cases and students at present. Similarly, patients without ADRs as well as the treatment of patient could be added to provide a more realistic setting and address the training aspect in more detail. Furthermore, the expansion of the application in the training of other healthcare professions, which are also related to the topic of ADRs and their recognition or patients, should be the subject of further investigation. Nursing and pharmaceutical professions could also benefit from using the game. A second version of the game is currently being developed that considers treatment of patients, patients without ADRs, other professions, and factors such as the seriousness and urgency of a case, which can be addressed in the game.
Conclusion
Overall, the study indicates that the implementation of new digital learning tools in pharmacology training, specifically in pharmacovigilance, can be successful and can improve knowledge in the field of ADRs. It offers an additional tool to the existing training formats and may in future potentially even provide an EU-wide training platform for the recognition and treatment of ADRs.
Data availability
The datasets generated during the current study are available from the corresponding author on reasonable request.
References
Just KS, Dormann H, Schurig M, Böhme M, Steffens M, Plank-Kiegele B, Ettrich K, Seufferlein T, Gräff I, Igel S et al (2020) The phenotype of adverse drug effects: do emergency visits due to adverse drug reactions look different in older people? Results from the ADRED study. Br J Clin Pharmacol 86:2144–2154
Just KS, Dormann H, Böhme M, Schurig M, Schneider KL, Steffens M, Dunow S, Plank-Kiegele B, Ettrich K, Seufferlein T et al (2020) Personalising drug safety—results from the multi-centre prospective observational study on adverse drug reactions in emergency departments (ADRED). Eur J Clin Pharmacol 76:439–448
Just KS, Dormann H, Schurig M, Böhme M, Fracowiak J, Steffens M, Scholl C, Seufferlein T, Gräff I, Schwab M, Stingl JC (2020) Adverse drug reactions in the emergency department: is there a role for pharmacogenomic profiles at risk?-Results from the ADRED study. J Clin Med 9(6):1801
Swen JJ, van der Wouden CH, Manson LEN, Abdullah-Koolmees H, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung K-C et al (2023) A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. The Lancet 401:347–356
Schurig AM, Bohme M, Just KS, Scholl C, Dormann H, Plank-Kiegele B, Seufferlein T, Graff I, Schwab M, Stingl JC (2018) Adverse drug reactions (ADR) and emergencies. Dtsch Arztebl Int 115:251–258
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329:15–19
Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL (2006) National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296:1858–1866
Lavertu A, Vora B, Giacomini KM, Altman R, Rensi S (2021) A new era in pharmacovigilance: Toward real-world data and digital monitoring. Clin Pharmacol Ther 109:1197–1202
Reumerman M, Tichelaar J, Piersma B, Richir MC, van Agtmael MA (2018) Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Eur J Clin Pharmacol 74:1235–1248
van Eekeren R, Rolfes L, Koster AS, Magro L, Parthasarathi G, Al Ramimmy H, Schutte T, Tanaka D, van Puijenbroek E, Härmark L (2018) What future healthcare professionals need to know about pharmacovigilance: introduction of the WHO PV core curriculum for university teaching with focus on clinical aspects. Drug Saf 41:1003–1011
Istadi Y, Raharjo TJ, Azam M, Mulyono SE (2022) Academic performance in medical education during the COVID-19 pandemic: a scoping review. Adv Med Educ Pract 13:1423–1438
Kaul V (2021) Gallo de Moraes A, Khateeb D, Greenstein Y, Winter G, Chae J, Stewart NH, Qadir N, Dangayach NS: Medical education during the COVID-19 pandemic. Chest 159:1949–1960
Gentry SV, Gauthier A, L’Estrade Ehrstrom B, Wortley D, Lilienthal A, Tudor Car L, Dauwels-Okutsu S, Nikolaou CK, Zary N, Campbell J, Car J (2019) Serious gaming and gamification education in health professions: systematic review. J Med Internet Res 21:e12994
Tubelo RA, Portella FF, Gelain MA, de Oliveira MMC, de Oliveira AEF, Dahmer A, Pinto MEB (2019) Serious game is an effective learning method for primary health care education of medical students: a randomized controlled trial. Int J Med Inform 130:103944
Xu M, Luo Y, Zhang Y, Xia R, Qian H, Zou X (2023) Game-based learning in medical education. Front Public Health 11:1113682
Cain J, Piascik P (2015) Are serious games a good strategy for pharmacy education? Am J Pharm Educ 79:47
Sera L, Wheeler E (2017) Game on: the gamification of the pharmacy classroom. Curr Pharm Teach Learn 9:155–159
Aburahma MH, Mohamed HM (2015) Educational games as a teaching tool in pharmacy curriculum. Am J Pharm Educ 79:59
GmbH L (2022) LimeSurvey: an open source survey tool. http://www.limesurvey.org . Accessed 03 Jun 2024
Brooke J (1996) SUS-A quick and dirty usability scale. Usability Eval Ind 189(194):4–7
Brooke J (2013) SUS: a retrospective. J Usability Stud 8:29–40
RC T (2021) R: a language and environment for statistical computing. https://www.R-project.org/. Accessed 03 June 2024
van Gaalen AEJ, Brouwer J, Schönrock-Adema J, Bouwkamp-Timmer T, Jaarsma ADC, Georgiadis JR (2021) Gamification of health professions education: a systematic review. Adv Health Sci Educ Theory Pract 26:683–711
Evans WE, Relling MV (1999) Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286:487–491
Relling MV, Evans WE (2015) Pharmacogenomics in the clinic. Nature 526:343–350
Just KS, Steffens M, Swen JJ, Patrinos GP, Guchelaar H-J, Stingl JC (2017) Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx). Eur J Clin Pharmacol 73:1247–1252
Just KS, Turner RM, Dolžan V, Cecchin E, Swen JJ, Gurwitz D, Stingl JC (2019) Educating the next generation of pharmacogenomics experts: global educational needs and concepts. Clin Pharmacol Ther 106:313
Jose J, van Eekeren R, Jimmy B (2021) Medication safety education through games: a potential approach to educate healthcare students on adverse drug reactions. Int J Pharm Pract 29:91–92
Andrès E, Federici L, Weitten T, Vogel T, Alt M (2008) Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis. Expert Opin Drug Saf 7:481–489
Acknowledgements
We would like to thank all the students who participated in the current study.
Funding
Open Access funding enabled and organized by Projekt DEAL. This study has received funding from the European Community’s Horizon 2020 Programme under grant agreement No. 668353 (Ubiquitous Pharmacogenomics). This study has received funding from the Exploratory Teaching Space (ETS) of the RWTH Aachen University under the grant agreement G:(DE-82) ETS-ETS-ETS468. This project is funded by the Innovation in Higher Education Foundation under grant agreement: FR-232/2023.
Author information
Authors and Affiliations
Contributions
All authors, IB, LB, SF, TK, ML, JCS, and KSJ, contributed to the study conception and design. Material preparation, data collection and analysis were performed by IB, LB and KSJ. Game and study concipation was done by IB, LB, SF, ML, JCS, and KSJ. TK supported in the study analysis. The first draft of the manuscript was written by IB, L and KSJ and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Ingmar Bergs and Laura Bell shared first authorship.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bergs, I., Bell, L., Fedrowitz, S. et al. Serious gaming as potential training tool for recognition of adverse drug reactions: side-effect exposure—medical education (SeeMe). Eur J Clin Pharmacol (2024). https://doi.org/10.1007/s00228-024-03739-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00228-024-03739-w